Establishing the Registry of Korean Patients With Borderline Ovarian Tumors
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
- 试验地点
- 4
- 主要终点
- Recurrence-free survival
研究概览
简要总结
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
详细描述
The researchers retrospectively collected data on Korean patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. And the researchers prospectively will collect data on all Korean patients with BOTs at institutions where placed in the Republic of Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
- •All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015
排除标准
- •Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis
结局指标
主要结局
Recurrence-free survival
时间窗: up to 100 months
次要结局
未报告次要终点
研究者
Taejong Song
Professor
Kangbuk Samsung Hospital
